Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2048826
Max Phase: Preclinical
Molecular Formula: C32H41N9O11
Molecular Weight: 727.73
Molecule Type: Small molecule
Associated Items:
ID: ALA2048826
Max Phase: Preclinical
Molecular Formula: C32H41N9O11
Molecular Weight: 727.73
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 3'-Hydroxypacidamycin D
Synonyms from Alternative Forms(1):
Canonical SMILES: C[C@H](N)C(=O)N(C)[C@@H](C)[C@H](NC(=O)[C@H](C)NC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(=O)N/C=C1\O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C32H41N9O11/c1-14(33)28(47)40(4)16(3)23(27(46)35-13-21-24(43)25(44)29(52-21)41-10-9-22(42)38-32(41)51)39-26(45)15(2)36-31(50)37-20(30(48)49)11-17-12-34-19-8-6-5-7-18(17)19/h5-10,12-16,20,23-25,29,34,43-44H,11,33H2,1-4H3,(H,35,46)(H,39,45)(H,48,49)(H2,36,37,50)(H,38,42,51)/b21-13-/t14-,15-,16-,20-,23-,24+,25+,29+/m0/s1
Standard InChI Key: OOMGUJKOXVKRQJ-MNRPCKSNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 727.73 | Molecular Weight (Monoisotopic): 727.2926 | AlogP: -2.71 | #Rotatable Bonds: 13 |
Polar Surface Area: 303.30 | Molecular Species: ACID | HBA: 12 | HBD: 10 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.89 | CX Basic pKa: 8.36 | CX LogP: -5.67 | CX LogD: -5.71 |
Aromatic Rings: 3 | Heavy Atoms: 52 | QED Weighted: 0.09 | Np Likeness Score: 0.01 |
1. Okamoto K, Sakagami M, Feng F, Takahashi F, Uotani K, Togame H, Takemoto H, Ichikawa S, Matsuda A.. (2012) Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction., 22 (14): [PMID:22677318] [10.1016/j.bmcl.2012.05.050] |
2. Terasawa Y,Sataka C,Sato T,Yamamoto K,Fukushima Y,Nakajima C,Suzuki Y,Katsuyama A,Matsumaru T,Yakushiji F,Yokota SI,Ichikawa S. (2020) Elucidating the Structural Requirement of Uridylpeptide Antibiotics for Antibacterial Activity., 63 (17): [PMID:32787111] [10.1021/acs.jmedchem.0c00973] |
Source(1):